Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
54,909,739
-
Shares change
-
+7,941,005
-
Total reported value, excl. options
-
$1,262,978,377
-
Value change
-
+$181,552,159
-
Put/Call ratio
-
29%
-
Number of buys
-
58
-
Number of sells
-
-17
-
Price
-
$23.01
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q3 2021
94 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share as of Q3 2021.
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,909,739 shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (22,061,374 shares), Laurion Capital Management LP (3,923,713 shares), VANGUARD GROUP INC (2,711,980 shares), ARK Investment Management LLC (2,593,836 shares), FMR LLC (1,959,963 shares), BlackRock Inc. (1,767,659 shares), STATE STREET CORP (1,644,494 shares), ALLIANCEBERNSTEIN L.P. (1,639,341 shares), HARVARD MANAGEMENT CO INC (1,509,254 shares), and CREDIT SUISSE AG/ (1,450,596 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.